TY  - GEN 
AU  - Hernández-Boluda, J.-C.
AU  - Pereira, A.
AU  - Alvarez-Larran, A.
AU  - Martín, A.-A.
AU  - Benzaquen, A.
AU  - Aguirre, L.
AU  - Mora, E.
AU  - González, P.
AU  - Mora, J.
AU  - Dorado, N.
AU  - Sampol, A.
AU  - García-Gutiérrez, V.
AU  - López-Godino, O.
AU  - Fox, M.-L.
AU  - Reguera, J.L.
AU  - Pérez Encinas, Manuel Mateo
AU  - Pascual, M.-J.
AU  - Xicoy, B.
AU  - Parody, R.
AU  - González-Pinedo, L.
AU  - Español, I.
AU  - Avendaño, A.
AU  - Correa, J.-G.
AU  - Vallejo Llamas, Juan Carlos
AU  - Jurado, M.
AU  - García-Cadenas, I.
AU  - Osorio, S.
AU  - Durán, M.-A.
AU  - Sánchez-Guijo, F.
AU  - Cervantes, F.
AU  - Piñana, J.-L.
PY  - 2020
SN  - 1523-6536
UR  - http://hdl.handle.net/20.500.11940/20373
AB  - Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed to evaluate the performance of the Myelofibrosis Transplant Scoring System...
LA  - eng
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Primary Myelofibrosis
KW  - Prognosis
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Treatment Outcome
TI  - Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
DO  - 10.1016/J.BBMT.2020.07.022
KW  - AS Santiago AP
KW  - CHUS
KW  - IDIS
VL  - 26
ER  -